Tulip Biosciences

Startup
Summarized by Halo AI

Tulip Biosciences develops nature-inspired, mucus-derived biomaterials that restore mucosal health. Their platform provides microbiome-friendly solutions for women's health, wound care, and chronic conditions by supporting natural barrier function.

Founded & HQ
Woburn, MA, USA
Activity highlights
Developing a pipeline of mucus-inspired biomaterials including TLP-401 for vaginal barrier support and TLP-402 for recurrent bacterial vaginosis therapy.

Tulip Biosciences is a platform company developing nature-inspired, mucus-derived biomaterials designed to support and restore the body's mucosal surfaces. By utilizing mucin glycans, the company creates tunable, microbiome-friendly materials that hydrate, buffer, and guide microbial ecosystems through biochemical modulation rather than toxicity. Their technology aims to work in harmony with biological systems to provide safe, effective, and sustainable solutions that address both clinical and consumer health needs.

The company’s approach is particularly focused on areas where mucosal barriers are compromised, including women's health, wound care, and gut health. By rebuilding these natural protective barriers, Tulip Biosciences addresses chronic conditions such as recurrent bacterial vaginosis, dryness, irritation, and inflammation. Their development pipeline spans multiple applications, from vaginal barrier support and non-hormonal contraception to ocular care and cosmeceuticals, with a broader mission to translate biological evolution into innovative therapeutic and wellness products.

AI summary generated on Jun 4, 2026
OpenAlexOpenAlex

For general inquiries

Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.